Darshan Kulkarni’s Post

Does AI overpromise its clinical research influence? With its ability to improve efficiency and enhance outcomes, the potential is enormous! Tune into my podcast to explore AI's role in drug development. Link in comments. #clinicaltrials #healthtech #AI #kulkarnilawfirm #klf

Is AI overhyped in clinical research? Can we harness it ethically? Listen to my podcast to explore the opportunities and challenges in drug development. Click below. #clinicalresearch #AIandpharma #healthcareinnovation #kulkarnilawfirm #klf

𝘼𝙧𝙚 𝙮𝙤𝙪 𝙮𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙩𝙤 𝙩𝙖𝙠𝙚 𝘼𝙄 𝙛𝙧𝙤𝙢 𝙖𝙣𝙖𝙡𝙮𝙩𝙞𝙘𝙖𝙡 𝙩𝙤 𝙞𝙣𝙨𝙞𝙜𝙝𝙩𝙛𝙪𝙡? 𝗖𝗜𝗔𝗜𝗥𝗔™ is BioVid's Proprietary AI Tool Trained in Cognitive Science. We have integrated evidence-based intellectual capital and cognitive and behavioral sciences into a proprietary AI tool that meets the rigorous privacy demands of healthcare research in the pharmaceutical industry.  𝗖𝗜𝗔𝗜𝗥𝗔™ 𝗵𝗲𝗹𝗽𝘀 𝗺𝗮𝗿𝗸𝗲𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗮𝗻𝗱 𝗺𝗮𝗿𝗸𝗲𝘁𝗲𝗿𝘀:  𝗠𝗼𝘁𝗶𝘃𝗮𝘁𝗲 𝗔𝗰𝘁𝗶𝗼𝗻 Generate data-driven insight into what motivates and demotivates action 𝗔𝗴𝗴𝗿𝗲𝗴𝗮𝘁𝗲 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 Synthesize findings across past studies for fresh insight & research instrument optimization 𝗜𝗹𝗹𝘂𝗺𝗶𝗻𝗮𝘁𝗲 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 Create psychological insights into segments that are durable and actionable 𝗧𝗼 𝘀𝗰𝗵𝗲𝗱𝘂𝗹𝗲 𝗮 𝗖𝗜𝗔𝗜𝗥𝗔™ 𝗱𝗲𝗺𝗼, 𝗲𝗺𝗮𝗶𝗹 𝗶𝗻𝗳𝗼@𝗯𝗶𝗼𝘃𝗶𝗱.𝗰𝗼𝗺 𝘁𝗼𝗱𝗮𝘆!  #CIAIRA #thinkbiovid #cognitiveAI #cognitivescience #AI

𝘼𝙧𝙚 𝙮𝙤𝙪 𝙮𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙩𝙤 𝙩𝙖𝙠𝙚 𝘼𝙄 𝙛𝙧𝙤𝙢 𝙖𝙣𝙖𝙡𝙮𝙩𝙞𝙘𝙖𝙡 𝙩𝙤 𝙞𝙣𝙨𝙞𝙜𝙝𝙩𝙛𝙪𝙡? 𝗖𝗜𝗔𝗜𝗥𝗔™ is BioVid's Proprietary AI Tool Trained in Cognitive Science. We have integrated evidence-based intellectual capital and cognitive and behavioral sciences into a proprietary AI tool that meets the rigorous privacy demands of healthcare research in the pharmaceutical industry. 𝗖𝗜𝗔𝗜𝗥𝗔™ 𝗵𝗲𝗹𝗽𝘀 𝗺𝗮𝗿𝗸𝗲𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗮𝗻𝗱 𝗺𝗮𝗿𝗸𝗲𝘁𝗲𝗿𝘀: 𝗠𝗼𝘁𝗶𝘃𝗮𝘁𝗲 𝗔𝗰𝘁𝗶𝗼𝗻 Generate data-driven insight into what motivates and demotivates action 𝗔𝗴𝗴𝗿𝗲𝗴𝗮𝘁𝗲 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 Synthesize findings across past studies for fresh insight & research instrument optimization 𝗜𝗹𝗹𝘂𝗺𝗶𝗻𝗮𝘁𝗲 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 Create psychological insights into segments that are durable and actionable 𝗧𝗼 𝘀𝗰𝗵𝗲𝗱𝘂𝗹𝗲 𝗮 𝗖𝗜𝗔𝗜𝗥𝗔™ 𝗱𝗲𝗺𝗼, 𝗲𝗺𝗮𝗶𝗹 𝗶𝗻𝗳𝗼@𝗯𝗶𝗼𝘃𝗶𝗱.𝗰𝗼𝗺 𝘁𝗼𝗱𝗮𝘆! #CIAIRA #thinkbiovid #cognitiveAI #cognitivescience #AI

AI can make observational research more efficient than was ever before possible, but in a recent survey of webinar attendees, 73% of participants said "limited understanding of AI was a barrier to adoption". Watch this on-demand webinar to learn what considerations to make when evaluating the use of AI in research, and how these new technologies can simply research processes: https://lnkd.in/e3hx9uHs #webinar #pharma #observationalresearch #AI

Evil force or cure-all? AI, or artificial intelligence, is a discovery approach so powerful, we assume either the worst or best from it. The truth is, as the Project ALS Therapeutics Core integrates aspects of AI, drug discovery happens faster. The Core uses AI to identify drug targets that would have taken researchers years to find. The Core uses AI to identify the earliest physical changes in ALS. The Core uses AI to work with drug companies to design more humane and powerful ALS clinical trials. AI comes to the Core as a force for good, better, and best--resulting in tools and therapies that will slow and stop ALS. #AI #ALS #ALSResearch

AI has the potential to transform all sectors of healthcare, but two fields stand to see the biggest transformation, according to an article published by J.P. Morgan. “While artificial intelligence can potentially transform healthcare in general, drug discovery and diagnostics are two areas that may see the largest impacts in the foreseeable future.” Read the full article here: https://hubs.la/Q02wPK2z0 #DigitalDiagnostics #LumineticsCore #AI #Healthcare

🚀 Revolutionizing Drug Discovery with AI 🧬💡 As drug discovery becomes increasingly complex, expensive, and challenging, innovation is crucial for companies to stay ahead. While scientific advancements and cutting-edge drug technologies are essential, artificial intelligence (AI) is set to transform decision-making at the core of R&D efficiency. 🤖✨ In our latest white paper, Norstella shares its vision for integrating AI with our industry-leading data and advisory services. From pipeline to patient, we're embedding AI to develop next-generation solutions. These solutions will empower biopharma professionals to better contextualize challenges, predict outcomes, and guide decisions for optimal results. 📊🔍 The first tools are already available on the market, and we're continuing to develop at a rapid pace. 💡💼 https://lnkd.in/eYJtkkqA #DrugDiscovery #Innovation #ArtificialIntelligence #Biopharma #R&D #Healthcare #ClinicalOperations #Citeline #ClinicalDevelopment #AI

𝗪𝗵𝗮𝘁 𝗶𝘀 𝘁𝗵𝗲 𝘀𝘁𝗮𝘁𝗲 𝗼𝗳 𝗔𝗜/𝗠𝗟 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗶𝗻 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝘆?💡 Following the interesting panel discussion at the Discngine Meetup, we’ve summarized expert insights from both pharma and academia in a blog post. Discover the current status and impact of new technologies supporting antibody developability, as well as future trends in the field: https://bit.ly/4hRnKT3 Anything you would like to add? Write us in the comments! 👇 #discngine #antibody #discovery #developability #assessment #ai

The future of #biopharma R&D is here! Join us for a discussion with Malay Gandhi and DeAnna Zacherl on implementing a tech strategy that connects, collaborates, and tames chaos. Learn from the State of Tech in Biopharma Report and stay ahead in the era of #AI and complex datasets. Download today! https://lnkd.in/efnNJgf8